Evidence map›Paper›PMID 31162089›Full record

ArticleThe Lancet. Oncology2019

Cancer hospital advertising and outcomes: trust the messenger?

Allison Lipitz-Snyderman, Laura Vater, Michael Curry, Diane Li, David M Rubin, Mark Radzyner, Elaine Duck, Peter B Bach, Yael Schenker

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Allison Lipitz-SnydermanCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA. Electronic address: snyderma@mskcc.org.
Laura VaterDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Michael CurryCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA.
Diane LiCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA.
David M RubinDepartment of Finance, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA.
Mark RadzynerDepartment of Finance, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA.
Elaine DuckDepartment of Finance, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA.
Peter B BachCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY 10017, USA.
Yael SchenkerDivision of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, PA, USA.
Memorial Sloan Kettering Cancer Center · USIndiana University – Purdue University Indianapolis · USUniversity of Pittsburgh · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

TrustAdvertisingCancer Care FacilitiesHumansMarketing of Health ServicesNeoplasmsPrognosis

Identifiers

PMID31162089
PMCPMC7539685
OpenAlexW2947446522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.